Emerging therapy for endometriosis

Bibliography

• Burney RO, Guidice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril 2012;98(3):511-19
   PubMed Web of Science ®Google Scholar
• Petraglia F, Hornung D, Seitz C, et al. Reduced pelvic pain in women with endometriosis: efficacy of long-term Dienogest treatment. Arch Gynecol Obstet 2012;285(1):167-73
   PubMed Web of Science ®Google Scholar
• Falcone T, Lebovic DI. Clinical management of endometriosis. Obstet Gynecol 2011;118(3):691-705
   PubMed Web of Science ®Google Scholar
• Carvalho L, Podgaec S, Bellodi-Privato M, et al. Role of eutopic endometrium in pelvic endometriosis. J Minim Invasive Gynecol 2011;18(4):419-27
   PubMed Web of Science ®Google Scholar
• Meresman GF, Auge L, Baranao RI, et al. Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis. Fertil Steril 2002;77(6):1141-7
   PubMed Web of Science ®Google Scholar
• Beliard A, Agnes N, Foidart J-M. Reduction of apoptosis and proliferation in endometriosis. Fertil Steril 2004;82(1):80-5
   PubMed Web of Science ®Google Scholar
• Chwalisz K, Perez MC, DeMannon D, et al. Selective progesterone receptor modulator development and Use in the treatment of leiomyomata and endometriosis. Endocr Rev 2005;26(3):423-38
   PubMed Web of Science ®Google Scholar
• Santulli P, Borghese B, Noel JC, et al. Hormonal therapy deregulates prostaglandin-endoperoxidase synthase 2 (PTGS2) expression in endometriotic tissues. J Clin Endocrinol Metab 2014;99(3):881-90
   PubMed Web of Science ®Google Scholar
• Dassen H, Punyadeera C, Kamps R, et al. Estrogen metabolizing enzymes in endometrium and endometriosis. Hum Reprod 2007;22(12):3148-58
   PubMed Web of Science ®Google Scholar
• Missmer SA, Hankinson SE, Spiegelman D, et al. Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol 2004;160(8):784-96
   PubMed Web of Science ®Google Scholar
• Crosignani PG, Luciano A, Ray A, Bergqvist A. Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain. Hum Reprod 2006;21(1):248-56
   PubMed Web of Science ®Google Scholar
• Gomes MKO, Rosa-e-Silva JC, Garcia SB, et al. Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, fas expression and steroid receptors in endometriosis lesions and normal endometrium. Hum Reprod 2009;24(11):2736-45
   PubMed Web of Science ®Google Scholar
• Luciano A. Danazol treatment of endometriosis-associated pain. J Minim Invasive Gynecol 2006;13(6):523-4
   PubMed Web of Science ®Google Scholar
• Razzi S, Luisi S, Calonaci F, et al. Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis. Fertil Steril 2007;88(4):789-94
   PubMed Web of Science ®Google Scholar
• Cobellis L, Razzi S, Fava A, et al. A danazol-loaded intrauterine device decreases dysmenorrhea, pelvic pain, and dyspareunia associated with endometriosis. Fertil Steril 2004;82(1):239-40
   PubMed Web of Science ®Google Scholar
• Allen C, Hopewell S, Prentice A, Gregory D. Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev 2009;2(11):1-19
   Google Scholar
• Cobellis L, Razzi S, De Simone S, et al. The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis. Eur J Obstet Gynecol and Reprod Biol 2004;116(1):100-2
   PubMed Web of Science ®Google Scholar
• Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility. 7th edition. Lippincott Williams & Wilkins; 2004
   Google Scholar
• Harada T, Momoeda M, Taketani Y, et al. Dienogest is as effective as intranasal buserelin acetate for the relief of painsymptoms associated with endometriosis, a randomized, double blind multicenter, controlled trial. Fertil Steril 2009;91(3):675-81
   PubMed Web of Science ®Google Scholar
• Strowitzki T, Marr J, Gerlinger C, et al. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre open-label trial. Hum Reprod 2010;25(3):633-41
   PubMed Web of Science ®Google Scholar
• Tanmahasamut P, Rattanachaiyanont M, Angsuwathana S, et al. Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain. Obstet Gynecol 2012;119(3):519-26
   PubMed Web of Science ®Google Scholar
• Vercellini P, Crosignani PG, Somigliana E, et al. Medical treatment for rectovaginal endometriosis: what is the evidence? Hum Reprod 2009;24(10):2504-14
   PubMed Web of Science ®Google Scholar
• Petta CA, Ferriani RA, Abrao MS, et al. Randomized clinical trial of levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod 2005;20(7):1993-8
   PubMed Web of Science ®Google Scholar
• Carr B, Dmowski WP, O’Brien C, et al. Elagolix, an oral GnRH antagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: Effects on Bone Mineral Density. Reprod Sci 2014;21(11):1341-51
   PubMed Web of Science ®Google Scholar
• Bayoglu Tekin Y, Dilbaz B, Kiykac Altinbas SK, Dilbaz S. Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue. Fertil Steril 2011;95(2):492-6
   PubMed Web of Science ®Google Scholar
• Vercellini P, Frontino G, De Giorgi O, et al. Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil Steril 2003;80(3):560-3
   PubMed Web of Science ®Google Scholar
• The Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis. Fertil Steril 2008;90(3):S260-S69
   PubMedGoogle Scholar
• Seracchioli R, Mabrouk M, Frasca C, et al. Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrance: a randomized controlled trial. Fertil Steril 2010;93(1):52-6
   PubMed Web of Science ®Google Scholar
• Vlahos N, Vlachos A, Triantafyllidou O, et al. Continous versus cyclic use of oral contraceptives after surgery for symptomatic endometriosis: a prospective cohort study. Fertil Steril 2013;100(5):1337-42
   PubMed Web of Science ®Google Scholar
• Vercellini P, Somigliana E, Daguati R, et al. Postoperative oral contraceptive exposure and risk of endometrioma recurrence. Am J Obstet and Gynecol 2008;198(5):504-6
   PubMed Web of Science ®Google Scholar
• Chapron C, Souza C, Borghese B, et al. Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis. Hum Reprod 2011;26(8):2028-35
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. U.S. medical eligibility criteria for contraceptive use. MMWR Recomm Rep 2010;18(59):1-86
   Google Scholar
• Zupi E, Marconi D, Sbracia M, et al. Add-back therapy in the treatment of endometriosis-associated pain. Fertil Steril 2004;82(5):1303-8
   PubMed Web of Science ®Google Scholar
• Franke HR, van de Weijer PHM, Pennings TMM, van der Mooren MJ. Gonadotropin-releasing hormone agonist plus "add-back" hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial. Fertil Steril 2000;74(3):534-9
   PubMed Web of Science ®Google Scholar
• Paoletti AM, Serra GC, Cagnacci A, et al. Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment. Fertil Steril 1996;65(4):707-10
   PubMed Web of Science ®Google Scholar
• Guzick DS, Huang L-S, Broadman BA, et al. Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain. Fertil Steril 2011;95(5):1568-73
   PubMed Web of Science ®Google Scholar
• Diamond MP, Carr B, Dmowski WP, et al. Elagolix treatment for endometriosis-associated pain: Results from a Phase 2, Randomized, Double-Blind, placebo-controlled Study. Reprod Sci 2014;21(2):363-71
   PubMed Web of Science ®Google Scholar
• Jacobson TZ, Duffy JM, Barlow D, et al. Laparoscopic surgery for pelvic pain associated with endometriosis (Review). Cochrane Database Syst Rev 2009;7(4):1-28
   Google Scholar
• Alborzi S, Hamedi B, Omidvar A, et al. A comparison of the effect of short-term aromatase inhibitor (letrozole) and GnRH agonist (triptorelin) versus case control on pregnancy rate and symptom and sign recurrence after laparoscopic treatment of endometriosis. Arch Gynecol and Obstet 2011;284(1):105-10
   PubMed Web of Science ®Google Scholar
• Abou-Setta AM, Houston B, Al-Inany HG, Farquar C. Levonorgestrel intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery. Cochrane Database Syst Rev 2013;1:1-33
   Google Scholar
• Serracchioli R, Mabrouk M, Frasca C, et al. Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial. Fertil Steril 2010;94(2):464-71
   PubMed Web of Science ®Google Scholar
• Somigliana E, Vercellini P, Vigano P, et al. Postoperative medical therapy after surgical treatment of endometriosis: From adjuvant therapy to tertiary prevention. J Minim Invasive Gynecol 2014;21(3):328-34
   PubMed Web of Science ®Google Scholar
• Ferrero S, Camerini G, Seracchiolo R, et al. Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis. Hum Reprod 2009;24(12):3033-41
   PubMed Web of Science ®Google Scholar
• Soysal S, Soysal ME, Ozer S, et al. The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial. Hum Reprod 2004;19(1):160-7
   PubMed Web of Science ®Google Scholar
• Takayama K, Zeitoun K, Gunby RT, et al. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril 1998;69(4):709-13
   PubMed Web of Science ®Google Scholar
• Fatemi H, Al-Turki H, Papanikolaou E, et al. Successful treatment of an aggressive recurrent post-menopausal endometriosis with an aromatase inhibitor. Reprod BioMedicine Online 2005;11(4):455-7
   PubMed Web of Science ®Google Scholar
• Mousa N, Bedaiwy M, Casper R. Aromatase inhibitors in the treatment of severe endometriosis. Obstet Gynecol 2007;109(6):1421-3
   PubMed Web of Science ®Google Scholar
• Remorgida V, Abbamonte LH, Ragni N, et al. Letrozole and desogestrel-only contraceptive pill for the treatment of stage IV endometriosis. Aust N Z J Obstet Gynecol 2007;47(3):222-5
   PubMed Web of Science ®Google Scholar
• Abushahin F, Goldman KN, Barbieri E, et al. Aromatase inhibition for refractory endometriosis-related chronic pelvic pain. Fertil Steril 2011;96(4):939-42
   PubMed Web of Science ®Google Scholar
• Ferrero S, Venturini PL, Gillott DJ, Remorgida V. Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial. Reprod Biol Endocrinol 2011;9(88):1-7
   PubMed Web of Science ®Google Scholar
• Amsterdam LL, Gentry W, Jobanputra S, et al. Anastrozole and oral contraceptives: a novel treatment for endometriosis. Fertil Steril 2005;84(2):300-4
   PubMed Web of Science ®Google Scholar
• Mei L, Bao J, Tang L, et al. A novel mifepristone-loaded implant for long-term treatment of endometriosis: In vitro and in vivo studies. Eur J Pharm Sci 2010;39(2010):421-7
   PubMed Web of Science ®Google Scholar
• Donnez J, Tomaszewski J, Vazquez F, et al. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med 2012;366(5):421-32
   PubMed Web of Science ®Google Scholar
• Chwalisz K, Elger W, Stickler T, et al. The effects of 1-month administration of asoprisnil (J867), a selective progesterone receptor modulator, in healthy premenopausal women. Hum Reprod 2005;20(4):1090-9
   PubMed Web of Science ®Google Scholar
• Bouchard P, Chabbert-Buffet N, Gauser BCJM. Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy, and safety. Fertil Steril 2011;96(5):1175-89
   PubMed Web of Science ®Google Scholar
• Kettel L, Murphy A, Morales A, et al. Treatment of endometriosis with the antiprogesterone mifepristone (RU486). Fertil Steril 1996;65(1):23-8
   PubMed Web of Science ®Google Scholar
• Mutter GL, Bergeron C, Deligdisch L, et al. The spectrum of endometrial pathology induced by progesterone receptor modulators. Mod Pathol 2008;21(5):591-8
   PubMed Web of Science ®Google Scholar
• Kulak Jr J, Fischer C, Komm B, Taylor HS. Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model. Endocrinology 2011;152(8):3226-32
   PubMed Web of Science ®Google Scholar
• Stratton P, Sinaii N, Segars J, et al. Return of chronic pelvic pain from endometriosis after raloxifene treatment. Obstet Gynecol 2008;111(1):88-96
   PubMed Web of Science ®Google Scholar
• Naqvui H, Sakr S, Presti T, et al. Treatment with bazedoxifene and conjugated estrogens results in regression of endometriosis in a murine model. Biol Reprod 2014;90(6):1-7
   Google Scholar
• Chabbert-Buffet N, Meduri G, Bouchard P, Spitz IM. Selective progesterone receptor modulators and progesterone antagonists: mechanism of action and clinical applications. Hum Reprod Update 2005;11(3):293-307
   PubMed Web of Science ®Google Scholar
• The Practice Committee of the American Society of Reproductive Medicine. Endometriosis and Infertility: a committee opinion. Fertil Steril 2012;98(3):591-8
   PubMed Web of Science ®Google Scholar
• Sallam NH, Garcia-Velasco JA, Dias S, Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis (Review). Cochrane Database Syst Rev 2006;1:1-19
   Google Scholar
• de Ziegler D, Gayet V, Aubriot FX, et al. Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes. Fertil Steril 2010;94(7):2796-9
   PubMed Web of Science ®Google Scholar
• Macer ML, Taylor HS. Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet Gynecol Clin North Am 2012;39(4):535-49
   PubMed Web of Science ®Google Scholar
• Johnson NP, Hummelshoj L. World endometriosis society montpellier consortium consensus on current management of endometriosis. Hum Reprod 2013;28(6):1552-68
   PubMed Web of Science ®Google Scholar
• Ailawadi RK, Jobanputra S, Kataria M, et al. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Fertil Steril 2004;81(2):290-6
   PubMed Web of Science ®Google Scholar